139 related articles for article (PubMed ID: 31942561)
1. Downregulation of HNRNPK in human cancer cells inhibits lung metastasis.
Li M; Zhang W; Yang X; Liu H; Cao L; Li W; Wang L; Zhang G; Gao R
Animal Model Exp Med; 2019 Dec; 2(4):291-296. PubMed ID: 31942561
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoprotein K promotes the progression of lung cancer by inhibiting the p53-dependent signaling pathway.
Li M; Yang X; Zhang G; Wang L; Zhu Z; Zhang W; Huang H; Gao R
Thorac Cancer; 2022 May; 13(9):1311-1321. PubMed ID: 35352475
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.
Chen X; Gu P; Xie R; Han J; Liu H; Wang B; Xie W; Xie W; Zhong G; Chen C; Xie S; Jiang N; Lin T; Huang J
J Cell Mol Med; 2017 Jul; 21(7):1266-1279. PubMed ID: 27862976
[TBL] [Abstract][Full Text] [Related]
4. Regulation and related mechanism of GSN mRNA level by hnRNPK in lung adenocarcinoma cells.
Liu XH; Ma J; Feng JX; Feng Y; Zhang YF; Liu LX
Biol Chem; 2019 Jun; 400(7):951-963. PubMed ID: 30771276
[TBL] [Abstract][Full Text] [Related]
5. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
[TBL] [Abstract][Full Text] [Related]
6. Circ-GALNT16 restrains colorectal cancer progression by enhancing the SUMOylation of hnRNPK.
Peng C; Tan Y; Yang P; Jin K; Zhang C; Peng W; Wang L; Zhou J; Chen R; Wang T; Jin C; Ji J; Feng Y; Tang J; Sun Y
J Exp Clin Cancer Res; 2021 Aug; 40(1):272. PubMed ID: 34452628
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 regulates postnatal lung repair after hyperoxia: role of β-catenin/hnRNPK signaling.
Yang G; Biswasa C; Lin QS; La P; Namba F; Zhuang T; Muthu M; Dennery PA
Redox Biol; 2013; 1(1):234-43. PubMed ID: 24024157
[TBL] [Abstract][Full Text] [Related]
8. DNA-methylation-induced silencing of DIO3OS drives non-small cell lung cancer progression via activating hnRNPK-MYC-CDC25A axis.
Zhang M; Wu J; Zhong W; Zhao Z; He W
Mol Ther Oncolytics; 2021 Dec; 23():205-219. PubMed ID: 34761103
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein (HnRNP) K genome-wide binding survey reveals its role in regulating 3'-end RNA processing and transcription termination at the early growth response 1 (EGR1) gene through XRN2 exonuclease.
Mikula M; Bomsztyk K; Goryca K; Chojnowski K; Ostrowski J
J Biol Chem; 2013 Aug; 288(34):24788-98. PubMed ID: 23857582
[TBL] [Abstract][Full Text] [Related]
10. hnRNPK-regulated LINC00263 promotes malignant phenotypes through miR-147a/CAPN2.
Lee WJ; Shin CH; Ji H; Jeong SD; Park MS; Won HH; Pandey PR; Tsitsipatis D; Gorospe M; Kim HH
Cell Death Dis; 2021 Mar; 12(4):290. PubMed ID: 33731671
[TBL] [Abstract][Full Text] [Related]
11. HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction.
Li Y; Yang Y; Ma Q; Cheng H; Wang H; Ma C; Li F; Zhao S; Li X; Qi Y; Gu Z
Int J Biol Sci; 2022; 18(16):6084-6101. PubMed ID: 36439880
[No Abstract] [Full Text] [Related]
12. Transcriptional regulation and ubiquitination-dependent regulation of HnRNPK oncogenic function in prostate tumorigenesis.
Wu HL; Li SM; Huang YC; Xia QD; Zhou P; Li XM; Yu X; Wang SG; Ye ZQ; Hu J
Cancer Cell Int; 2021 Dec; 21(1):641. PubMed ID: 34857003
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
Zhu XH; Wang JM; Yang SS; Wang FF; Hu JL; Xin SN; Men H; Lu GF; Lan XL; Zhang D; Wang XY; Liao WT; Ding YQ; Liang L
Int J Cancer; 2017 Jul; 141(1):172-183. PubMed ID: 28335083
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of nuclear heterogeneous nuclear ribonucleic protein K and estrogen receptor α in endometrial cancer.
Miki Y; Iwabuchi E; Takagi K; Suzuki T; Sasano H; Yaegashi N; Ito K
Pathol Res Pract; 2022 Mar; 231():153795. PubMed ID: 35134625
[TBL] [Abstract][Full Text] [Related]
15. HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway.
Huang H; Han Y; Yang X; Li M; Zhu R; Hu J; Zhang X; Wei R; Li K; Gao R
Oncotarget; 2017 Nov; 8(61):103364-103374. PubMed ID: 29262567
[TBL] [Abstract][Full Text] [Related]
16. Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.
Shin CH; Lee H; Kim HR; Choi KH; Joung JG; Kim HH
Cell Death Differ; 2017 Nov; 24(11):1861-1871. PubMed ID: 28708135
[TBL] [Abstract][Full Text] [Related]
17. PROX1 promotes breast cancer invasion and metastasis through WNT/β-catenin pathway via interacting with hnRNPK.
Zhu L; Tian Q; Gao H; Wu K; Wang B; Ge G; Jiang S; Wang K; Zhou C; He J; Liu P; Ren Y; Wang B
Int J Biol Sci; 2022; 18(5):2032-2046. PubMed ID: 35342346
[No Abstract] [Full Text] [Related]
18. Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway in Breast Cancer.
Iwabuchi E; Miki Y; Suzuki T; Hirakawa H; Ishida T; Sasano H
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806648
[TBL] [Abstract][Full Text] [Related]
19. The role of heterogeneous nuclear ribonucleoprotein K in the progression of chronic myeloid leukemia.
Du Q; Wang L; Zhu H; Zhang S; Xu L; Zheng W; Liu X
Med Oncol; 2010 Sep; 27(3):673-9. PubMed ID: 19653139
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of the heterogeneous nuclear ribonucleoprotein K as irradiation responsive protein related to migration.
Strozynski J; Heim J; Bunbanjerdsuk S; Wiesmann N; Zografidou L; Becker SK; Meierl AM; Gouveris H; Lüddens H; Grus F; Brieger J
J Proteomics; 2015 Jan; 113():154-61. PubMed ID: 25281771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
